Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29719620
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29719620
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Oncotarget
2018 ; 9
(26
): 18494-18509
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Connective tissue growth factor-specific monoclonal antibody inhibits growth of
malignant mesothelioma in an orthotopic mouse model
#MMPMID29719620
Ohara Y
; Chew SH
; Misawa N
; Wang S
; Somiya D
; Nakamura K
; Kajiyama H
; Kikkawa F
; Tsuyuki Y
; Jiang L
; Yamashita K
; Sekido Y
; Lipson KE
; Toyokuni S
Oncotarget
2018[Apr]; 9
(26
): 18494-18509
PMID29719620
show ga
Malignant mesothelioma is an aggressive neoplasm with no particularly effective
treatments. We previously reported that overexpression of connective tissue
growth factor (CTGF/CCN2) promotes mesothelioma growth, thus suggesting it as a
novel molecular target. A human monoclonal antibody that antagonizes CTGF
(FG-3019, pamrevlumab) attenuates malignant properties of different kinds of
human cancers and is currently under clinical trial for the treatment of
pancreatic cancer. This study reports the effects of FG-3019 on human
mesothelioma in vitro and in vivo. We analyzed the effects of FG-3019 on the
proliferation, apoptosis, migration/invasion, adhesion and anchorage-independent
growth in three human mesothelioma cell lines, among which ACC-MESO-4 was most
efficiently blocked with FG-3019 and was chosen for in vivo experiments. We also
evaluated the coexistent effects of fibroblasts on mesothelioma in vitro, which
are also known to produce CTGF in various pathologic situations. Coexistent
fibroblasts in transwell systems remarkably promoted the proliferation and
migration/invasion of mesothelioma cells. In orthotopic nude mice model, FG-3019
significantly inhibited mesothelioma growth. Histological analyses revealed that
FG-3019 not only inhibited the proliferation but also induced apoptosis in both
mesothelioma cells and fibroblasts. Our data suggest that FG-3019 antibody
therapy could be a novel additional choice for the treatment of mesothelioma.